組織診断薬市場：製品、技術、適応症、エンドユーザー別-2025-2030年の世界予測

組織診断薬市場は、2023年に83億米ドルと評価され、2024年には89億4,000万米ドルに達すると予測され、CAGR 7.76％で成長し、2030年には140億2,000万米ドルに達すると予測されています。

組織診断薬市場には、細胞レベルで病気を分析・検出するためのツールや技術が含まれ、主にがん診断の領域で使用されているが、感染症や病理組織学的研究など他の分野にも広がっています。組織診断薬の必要性は、個々の患者の病態に基づいたオーダーメイドの治療レジメンを可能にする精密医療における重要な役割によって強調されています。用途としては、免疫組織化学、in situハイブリダイゼーション、デジタル病理学、特殊染色などが挙げられるが、これらに限定されるものではなく、病院、研究所、診断クリニックなどで最終用途として重要視されています。組織診断薬市場の成長は、がんの有病率の増加、バイオマーカー研究の進歩、診断技術の技術革新などの要因によってもたらされます。注目すべきビジネスチャンスは、診断精度とワークフロー効率を高めるためのデジタル病理学とAI主導型アナリティクスの統合にあります。これは、スキル不足や迅速診断に対する需要の増加といった課題に対処するのに役立つ可能性があります。しかし、先進的な診断ツールやインフラのコストが高いこと、規制上の障壁があること、一部の地域では熟練した人材が不足していることなどが制限となり、導入率が鈍化しています。さらに、組織サンプルの保存と分析に特有の複雑さが、運用上の課題となることもあります。大きな可能性を秘めた研究開発分野には、ポイントオブケア検査用のポータブルで費用対効果の高い診断キットの開発や、病理学における予測分析のためのAIアルゴリズムのさらなる改良などがあります。同市場は、製品ポートフォリオと地域情勢別リーチの拡大を目指す有力企業が提携や合併を進めており、競合情勢が特徴となっています。個別化された医療ソリューションに対する消費者の需要と、特に新興国におけるヘルスケアインフラへの投資の増加は、大きな市場機会をもたらすと予想されます。企業は、テクノロジー企業や研究機関との戦略的提携に注力し、既存の限界に対処する革新的ソリューションを活用すべきです。

市場力学：急速に進化する組織診断薬市場の主要市場インサイトを公開

組織診断薬市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界のがん罹患率の増加
  • 個別化医療の利用拡大
  • 効果的な早期がん診断に関する認知度向上のための政府の取り組み
• 市場抑制要因
  • 組織診断にかかる高コストと償還の問題
• 市場機会
  • デジタルパソロジーの開始と自動化組織診断薬
  • 組織診断分野における革新的技術と機器の開発
• 市場の課題
  • 組織診断薬手技に伴う制限とプライバシーの問題

ポーターのファイブフォース：組織診断薬市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、組織診断薬市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：組織診断薬市場における外部からの影響の把握

外部マクロ環境要因は、組織診断薬市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析組織診断薬市場における競合情勢の把握

組織診断薬市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス組織診断薬市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、組織診断薬市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限はベンダーを明確かつ正確に区分し、ユーザーが戦略目標に最適なパートナーやソリューションを特定するのに役立ちます。

本レポートは、主要な注目分野を網羅した包括的な市場分析を提供しています：

1.市場の浸透度：業界主要企業の広範なデータを含む、現在の市場環境の詳細なレビュー。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中でがんの発生率が増加
    • 個別化医療の利用拡大
    • 効果的かつ早期のがん診断に関する意識を高める政府の取り組み
  • 抑制要因
    • 組織診断にかかる高額な費用と償還の問題
  • 機会
    • デジタル病理学と自動化の始まり組織診断薬
    • 組織診断分野における革新的な技術と機器の開発
  • 課題
    • 組織診断薬手順に関連する制限とプライバシーに関する懸念
• 市場セグメンテーション分析
  • 製品：診断用組織サンプルの効率的な処理と分析のための組織処理システムの普及
  • 技術：コンピュータ技術によるデジタル化された組織学的サンプルの管理のためのデジタル病理学技術の採用
  • 適応症：多数のがん種の検出と特徴付けにおける組織診断薬の指数関数的使用
  • エンドユーザー：臨床病理学研究室で組織診断薬を大幅に活用して患者ケアの質を向上
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 組織診断薬市場：製品別

• アクセサリー
• 消耗品
  • 抗体
  • キット
  • プローブ
  • 試薬
• 機器
  • スキャナー
  • スライド染色システム
  • 組織マイクロアレイ
  • 組織処理システム
• ソフトウェア

第7章 組織診断薬市場：技術別

• デジタル病理学とワークフロー
• 免疫組織化学
• インサイチューハイブリダイゼーション
• 特殊染色

第8章 組織診断薬市場適応症別

• 乳がん
• 胃がん
• リンパ腫
• 非小細胞肺がん
• 前立腺がん

第9章 組織診断薬市場：エンドユーザー別

• 臨床病理学
• 契約調査機関
• 病院
• 製薬団体
• 調査室

第10章 南北アメリカの組織診断薬市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の組織診断薬市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの組織診断薬市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • PathAI、バイオファーマラボの拡張を発表し、エンドツーエンドの中央病理学および組織学サービスを提供
  • Ibex、がん診断におけるAIの世界の導入を推進するためシリーズC資金調達で5,500万米ドルを調達
  • クエスト・ダイアグノスティクス、診断とグレーディングの改善を目指した新しい前立腺がん検査を発表
  • サイテラブス、南インド全域の病院と患者に診断サービスを拡大
  • バイオテクネ、空間生物学によるがん診断を強化するためルナフォアを買収
  • Lunaphoreが4,000万スイスフランを確保し、組織診断薬ソリューションのポートフォリオを強化
  • 免疫組織化学用の新しい試薬ソリューション「Optimer-Fc」の発売
  • アイベックスとアルバーノ・ラボラトリーズ、がん診断のためのAIの複数年、複数組織拡張契約を締結
  • ロシュ、コンパニオン診断を通じてパーソナライズされたヘルスケアを推進するためヤンセンとの提携を拡大
  • ガーダントヘルス、がんバイオマーカー検出を強化するため、ルニットのPd-L1向けAIベーススコアリングアルゴリズムをポートフォリオに統合
  • EprediaとAiforiaがRegenMed Hubイノベーションアクセラレーターに参加、再生医療におけるPHCグループのプレゼンス拡大パートナーシップが新たなRegenMed臨床試験カタリストプログラムへの道を開く
  • マイクロソフト、がんの診断と治療の進歩に向けペイジと提携
  • アジレントとアコヤ・バイオサイエンス、バイオ医薬品アプリケーション向けマルチプレックス組織アッセイ開発を推進する提携を発表
  • TempusがNGSベースの体外診断装置 xT CDxの米国FDA承認を取得
  • ROCHE組織診断薬がマラナ拡張プロジェクトを祝う

企業一覧

• Abbott Laboratories
• Abcam Plc
• Agilent Technologies, Inc.
• Atlas Antibodies AB
• Bio-Rad Laboratories, Inc.
• Bio-Techne Corporation
• Biogenex Laboratories Inc.
• BioIVT, LLC
• bioMerieux SA
• Cardinal Health, Inc.
• Castle Biosciences, Inc.
• Cell Signaling Technology, Inc.
• Diagnostic BioSystems Inc.
• F. Hoffmann-La Roche Ltd
• Leica Biosystems by Danaher Corporation
• McKesson Corporation
• Merck KGaA
• MILESTONE MEDICAL Srl
• PathAI, Inc.
• Pfizer Inc.
• PROGEN Biotechnik GmbH
• QIAGEN N.V.
• Quest Diagnostics Incorporated
• Sekisui Diagnostics, LLC
• Siemens Healthineers AG
• SLEE medical GmbH
• Thermo Fisher Scientific Inc.

LIST OF FIGURES

• FIGURE 1. TISSUE DIAGNOSTICS MARKET RESEARCH PROCESS
• FIGURE 2. TISSUE DIAGNOSTICS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. TISSUE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. TISSUE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. TISSUE DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. TISSUE DIAGNOSTICS MARKET DYNAMICS
• TABLE 7. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY KITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY PROBES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY SCANNERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY SLIDE-STAINING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY TISSUE MICROARRAYS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY TISSUE-PROCESSING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY DIGITAL PATHOLOGY & WORKFLOW, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY SPECIAL STAINING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY GASTRIC CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY CLINICAL PATHOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 41. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 42. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 43. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 44. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 45. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 46. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 47. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 48. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 49. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 50. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 51. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 52. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 53. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 54. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 55. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 56. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 57. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 59. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 60. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 61. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 62. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 63. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 64. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 65. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 66. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 67. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 68. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 69. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 72. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 73. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 74. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 75. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 76. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 77. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 79. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 80. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 81. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 82. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 83. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 84. AUSTRALIA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 85. AUSTRALIA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 86. AUSTRALIA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 87. AUSTRALIA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 88. AUSTRALIA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 89. AUSTRALIA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. CHINA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. CHINA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 92. CHINA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 93. CHINA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 94. CHINA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 95. CHINA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. INDIA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. INDIA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 98. INDIA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 99. INDIA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 100. INDIA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 101. INDIA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. INDONESIA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 103. INDONESIA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 104. INDONESIA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 105. INDONESIA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 106. INDONESIA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 107. INDONESIA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 108. JAPAN TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 109. JAPAN TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 110. JAPAN TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 111. JAPAN TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 112. JAPAN TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 113. JAPAN TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. MALAYSIA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 115. MALAYSIA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 116. MALAYSIA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 117. MALAYSIA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 118. MALAYSIA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 119. MALAYSIA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. PHILIPPINES TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 121. PHILIPPINES TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 122. PHILIPPINES TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 123. PHILIPPINES TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 124. PHILIPPINES TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 125. PHILIPPINES TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. SINGAPORE TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 127. SINGAPORE TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 128. SINGAPORE TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 129. SINGAPORE TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 130. SINGAPORE TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 131. SINGAPORE TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 132. SOUTH KOREA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 133. SOUTH KOREA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 134. SOUTH KOREA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 135. SOUTH KOREA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 136. SOUTH KOREA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 137. SOUTH KOREA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 138. TAIWAN TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 139. TAIWAN TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 140. TAIWAN TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 141. TAIWAN TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 142. TAIWAN TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 143. TAIWAN TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 144. THAILAND TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 145. THAILAND TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 146. THAILAND TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 147. THAILAND TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 148. THAILAND TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 149. THAILAND TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 150. VIETNAM TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 151. VIETNAM TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 152. VIETNAM TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 153. VIETNAM TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 154. VIETNAM TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 155. VIETNAM TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 156. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 157. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 158. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 159. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 160. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 161. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 162. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 163. DENMARK TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 164. DENMARK TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 165. DENMARK TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 166. DENMARK TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 167. DENMARK TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 168. DENMARK TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 169. EGYPT TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 170. EGYPT TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 171. EGYPT TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 172. EGYPT TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 173. EGYPT TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 174. EGYPT TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 175. FINLAND TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 176. FINLAND TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 177. FINLAND TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 178. FINLAND TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 179. FINLAND TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 180. FINLAND TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 181. FRANCE TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 182. FRANCE TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 183. FRANCE TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 184. FRANCE TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 185. FRANCE TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 186. FRANCE TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 187. GERMANY TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 188. GERMANY TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 189. GERMANY TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 190. GERMANY TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 191. GERMANY TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 192. GERMANY TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 193. ISRAEL TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 194. ISRAEL TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 195. ISRAEL TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 196. ISRAEL TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 197. ISRAEL TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 198. ISRAEL TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 199. ITALY TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 200. ITALY TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 201. ITALY TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 202. ITALY TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 203. ITALY TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 204. ITALY TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 205. NETHERLANDS TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 206. NETHERLANDS TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 207. NETHERLANDS TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 208. NETHERLANDS TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 209. NETHERLANDS TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 210. NETHERLANDS TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 211. NIGERIA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 212. NIGERIA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 213. NIGERIA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 214. NIGERIA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 215. NIGERIA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 216. NIGERIA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 217. NORWAY TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 218. NORWAY TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 219. NORWAY TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 220. NORWAY TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 221. NORWAY TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 222. NORWAY TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 223. POLAND TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 224. POLAND TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 225. POLAND TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 226. POLAND TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 227. POLAND TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 228. POLAND TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 229. QATAR TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 230. QATAR TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 231. QATAR TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 232. QATAR TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 233. QATAR TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 234. QATAR TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 235. RUSSIA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 236. RUSSIA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 237. RUSSIA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 238. RUSSIA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 239. RUSSIA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 240. RUSSIA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 241. SAUDI ARABIA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 242. SAUDI ARABIA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 243. SAUDI ARABIA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 244. SAUDI ARABIA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 245. SAUDI ARABIA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 246. SAUDI ARABIA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 247. SOUTH AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 248. SOUTH AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 249. SOUTH AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 250. SOUTH AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 251. SOUTH AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 252. SOUTH AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 253. SPAIN TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 254. SPAIN TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 255. SPAIN TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 256. SPAIN TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 257. SPAIN TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 258. SPAIN TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 259. SWEDEN TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 260. SWEDEN TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 261. SWEDEN TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 262. SWEDEN TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 263. SWEDEN TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 264. SWEDEN TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 265. SWITZERLAND TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 266. SWITZERLAND TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 267. SWITZERLAND TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 268. SWITZERLAND TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 269. SWITZERLAND TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 270. SWITZERLAND TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 271. TURKEY TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 272. TURKEY TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 273. TURKEY TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 274. TURKEY TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 275. TURKEY TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 276. TURKEY TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 277. UNITED ARAB EMIRATES TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 278. UNITED ARAB EMIRATES TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 279. UNITED ARAB EMIRATES TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 280. UNITED ARAB EMIRATES TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 281. UNITED ARAB EMIRATES TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 282. UNITED ARAB EMIRATES TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 283. UNITED KINGDOM TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 284. UNITED KINGDOM TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 285. UNITED KINGDOM TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 286. UNITED KINGDOM TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 287. UNITED KINGDOM TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 288. UNITED KINGDOM TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 289. TISSUE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 290. TISSUE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

The Tissue Diagnostics Market was valued at USD 8.30 billion in 2023, expected to reach USD 8.94 billion in 2024, and is projected to grow at a CAGR of 7.76%, to USD 14.02 billion by 2030.

The tissue diagnostics market encompasses tools and technologies used to analyze and detect diseases at the cellular level, primarily in the realm of cancer diagnostics but extending to other areas such as infectious diseases and histopathological studies. The necessity of tissue diagnostics is underscored by its critical role in precision medicine, enabling tailored treatment regimens based on individual patient pathology. Applications include but are not limited to, immunohistochemistry, in situ hybridization, digital pathology, and special staining, which find significant end-use in hospitals, research laboratories, and diagnostic clinics. Growth in the tissue diagnostics market is driven by factors such as the increasing prevalence of cancer, advances in biomarker research, and technological innovations in diagnostic techniques. A notable opportunity lies in the integration of digital pathology and AI-driven analytics to enhance diagnostic accuracy and workflow efficiency. This could help address challenges like skill shortages and the increasing demand for rapid diagnostics. Limitations, however, consist of the high costs of advanced diagnostic tools and infrastructure, regulatory barriers, and a lack of skilled personnel in some regions, slowing adoption rates. Additionally, the inherent complexity of tissue sample preservation and analysis can pose operational challenges. Innovation and research areas with significant potential include the development of portable, cost-effective diagnostic kits for point-of-care testing and the further refinement of AI algorithms for predictive analytics in pathology. The market is characterized by a competitive landscape with ongoing collaborations and mergers among prominent players aiming to expand their product portfolios and geographical reach. Consumer demand for personalized medical solutions and the increasing investment in healthcare infrastructure, particularly in emerging economies, are expected to provide substantial market opportunities. Companies should focus on strategic partnerships with technology firms and research institutions to harness innovative solutions that address existing limitations.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Tissue Diagnostics Market

The Tissue Diagnostics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing incidence of cancer worldwide
  • Growing use of personalized medicine
  • Government initiatives to increase awareness regarding effective and early cancer diagnosis
• Market Restraints
  • High cost involved in tissue diagnosis and reimbursement issues
• Market Opportunities
  • Inception of digital pathology and automated tissue diagnostics
  • Innovative technologies and instruments development in tissue diagnostic field
• Market Challenges
  • Limitations associated with tissue diagnostics procedures coupled with privacy concerns

Porter's Five Forces: A Strategic Tool for Navigating the Tissue Diagnostics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Tissue Diagnostics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Tissue Diagnostics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Tissue Diagnostics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Tissue Diagnostics Market

A detailed market share analysis in the Tissue Diagnostics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Tissue Diagnostics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Tissue Diagnostics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Tissue Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abcam Plc, Agilent Technologies, Inc., Atlas Antibodies AB, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Biogenex Laboratories Inc., BioIVT, LLC, bioMerieux SA, Cardinal Health, Inc., Castle Biosciences, Inc., Cell Signaling Technology, Inc., Diagnostic BioSystems Inc., F. Hoffmann-La Roche Ltd, Leica Biosystems by Danaher Corporation, McKesson Corporation, Merck KGaA, MILESTONE MEDICAL Srl, PathAI, Inc., Pfizer Inc., PROGEN Biotechnik GmbH, QIAGEN N.V., Quest Diagnostics Incorporated, Sekisui Diagnostics, LLC, Siemens Healthineers AG, SLEE medical GmbH, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Tissue Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Accessories, Consumables, Instruments, and Software. The Consumables is further studied across Antibodies, Kits, Probes, and Reagents. The Instruments is further studied across Scanners, Slide-staining Systems, Tissue Microarrays, and Tissue-processing Systems.
• Based on Technology, market is studied across Digital Pathology & Workflow, Immunohistochemistry, In Situ Hybridization, and Special Staining.
• Based on Indications, market is studied across Breast Cancer, Gastric Cancer, Lymphoma, Non Small Cell Lung Cancer, and Prostate Cancer.
• Based on End-User, market is studied across Clinical Pathology, Contract Research Organization, Hospitals, Pharmaceutical Organizations, and Research Laboratories.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing incidence of cancer worldwide
    • 5.1.1.2. Growing use of personalized medicine
    • 5.1.1.3. Government initiatives to increase awareness regarding effective and early cancer diagnosis
  • 5.1.2. Restraints
    • 5.1.2.1. High cost involved in tissue diagnosis and reimbursement issues
  • 5.1.3. Opportunities
    • 5.1.3.1. Inception of digital pathology and automated tissue diagnostics
    • 5.1.3.2. Innovative technologies and instruments development in tissue diagnostic field
  • 5.1.4. Challenges
    • 5.1.4.1. Limitations associated with tissue diagnostics procedures coupled with privacy concerns
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Proliferating use of tissue-processing systems for efficient processing and analyzing diagnosing tissue samples
  • 5.2.2. Technology: Adoption of digital pathology technology for the management of digitized histological samples through computer technology
  • 5.2.3. Indications: Exponential use of tissue diagnostics in the detection and characterization of numerous cancer types
  • 5.2.4. End-User: Significant utilization of tissue diagnostics in clinical pathology laboratories to improve patient care quality
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Tissue Diagnostics Market, by Product

• 6.1. Introduction
• 6.2. Accessories
• 6.3. Consumables
  • 6.3.1. Antibodies
  • 6.3.2. Kits
  • 6.3.3. Probes
  • 6.3.4. Reagents
• 6.4. Instruments
  • 6.4.1. Scanners
  • 6.4.2. Slide-staining Systems
  • 6.4.3. Tissue Microarrays
  • 6.4.4. Tissue-processing Systems
• 6.5. Software

7. Tissue Diagnostics Market, by Technology

• 7.1. Introduction
• 7.2. Digital Pathology & Workflow
• 7.3. Immunohistochemistry
• 7.4. In Situ Hybridization
• 7.5. Special Staining

8. Tissue Diagnostics Market, by Indications

• 8.1. Introduction
• 8.2. Breast Cancer
• 8.3. Gastric Cancer
• 8.4. Lymphoma
• 8.5. Non Small Cell Lung Cancer
• 8.6. Prostate Cancer

9. Tissue Diagnostics Market, by End-User

• 9.1. Introduction
• 9.2. Clinical Pathology
• 9.3. Contract Research Organization
• 9.4. Hospitals
• 9.5. Pharmaceutical Organizations
• 9.6. Research Laboratories

10. Americas Tissue Diagnostics Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Tissue Diagnostics Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Tissue Diagnostics Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. PathAI Announces Expansion of BioPharma Lab to Provide End-to-End Central Pathology and Histology Services
  • 13.3.2. Ibex Raises USD 55 Million in Series C Funding to Drive Global Adoption of AI for Cancer Diagnosis
  • 13.3.3. Quest Diagnostics Launches Novel Prostate Cancer Test Aimed at Improving Diagnosis and Grading
  • 13.3.4. Cytelabs expanding diagnostic services to hospitals and patients across south India
  • 13.3.5. Bio-Techne Buys Lunaphore to Boost Cancer Diagnostics Through Spatial Biology
  • 13.3.6. Lunaphore Secures Chf 40 Million to Boost Portfolio of Tissue Diagnostics Solutions
  • 13.3.7. Launch of Optimer-Fc as a New Reagent Solution for Immunohistochemistry
  • 13.3.8. Ibex and Alverno Laboratories Sign Multi-Year, Multi-Tissue Expansion Agreement of AI for Cancer Diagnosis
  • 13.3.9. Roche Expands Collaboration with Janssen to Advance Personalized Healthcare Through Companion Diagnostics
  • 13.3.10. Guardant Health to Integrate Lunit's Ai-Based Scoring Algorithm for Pd-L1 into its Portfolio to Enhance Cancer Biomarker Detection
  • 13.3.11. Epredia and Aiforia Join RegenMed Hub Innovation Accelerator, Expanding PHC Group Presence in Regenerative Medicine Partnership Will Pave the Way for New RegenMed Clinical Trials Catalyst Program
  • 13.3.12. Microsoft Strikes Partnership with Paige to Advance Cancer Diagnostics and Treatment
  • 13.3.13. Agilent and Akoya Biosciences Announce Partnership to Drive Multiplex Tissue Assay Development for Biopharma Applications
  • 13.3.14. Tempus Receives U.S. FDA Approval for xT CDx, a NGS-Based In Vitro Diagnostic Device
  • 13.3.15. ROCHE tissue diagnostics celebrates marana expansion project

Companies Mentioned

• 1. Abbott Laboratories
• 2. Abcam Plc
• 3. Agilent Technologies, Inc.
• 4. Atlas Antibodies AB
• 5. Bio-Rad Laboratories, Inc.
• 6. Bio-Techne Corporation
• 7. Biogenex Laboratories Inc.
• 8. BioIVT, LLC
• 9. bioMerieux SA
• 10. Cardinal Health, Inc.
• 11. Castle Biosciences, Inc.
• 12. Cell Signaling Technology, Inc.
• 13. Diagnostic BioSystems Inc.
• 14. F. Hoffmann-La Roche Ltd
• 15. Leica Biosystems by Danaher Corporation
• 16. McKesson Corporation
• 17. Merck KGaA
• 18. MILESTONE MEDICAL Srl
• 19. PathAI, Inc.
• 20. Pfizer Inc.
• 21. PROGEN Biotechnik GmbH
• 22. QIAGEN N.V.
• 23. Quest Diagnostics Incorporated
• 24. Sekisui Diagnostics, LLC
• 25. Siemens Healthineers AG
• 26. SLEE medical GmbH
• 27. Thermo Fisher Scientific Inc.